Last reviewed · How we verify

SNP-ACTH (1-39) Gel — Competitive Intelligence Brief

SNP-ACTH (1-39) Gel (SNP-ACTH (1-39) Gel) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: corticosteroid. Area: Endocrinology.

phase 3 corticosteroid melanocortin receptors Endocrinology Small molecule Live · refreshed every 30 min

Target snapshot

SNP-ACTH (1-39) Gel (SNP-ACTH (1-39) Gel) — Cerium Pharmaceuticals, Inc.. SNP-ACTH (1-39) Gel is a synthetic peptide that mimics the action of adrenocorticotropic hormone (ACTH) to stimulate the production of cortisol.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
SNP-ACTH (1-39) Gel TARGET SNP-ACTH (1-39) Gel Cerium Pharmaceuticals, Inc. phase 3 corticosteroid melanocortin receptors
H.P. ACTHAR SUBCUTANEOUS GEL INJECTION H.P. ACTHAR SUBCUTANEOUS GEL INJECTION Tampa Bay Uveitis Center, LLC marketed Corticotropin (ACTH) analog Melanocortin receptors (primarily MC2R on adrenal cortex; also MC1R, MC3R, MC4R, MC5R on immune cells)
Emflaza DEFLAZACORT Ptc Therap marketed Corticosteroid [EPC] 2017-01-01
Fluocinolone Acetonide FLUOCINOLONE Eurofarma marketed Corticosteroid [EPC] 2016-01-01
Arnuity Ellipta FLUTICASONE FUROATE Haleon Us Holdings marketed Corticosteroid Glucocorticoid receptor 2007-01-01
Lotemax LOTEPREDNOL ETABONATE Bausch Health marketed Corticosteroid Glucocorticoid receptor 1998-01-01
Pandel HYDROCORTISONE PROBUTATE ANI Pharmaceuticals marketed Corticosteroid Glucocorticoid receptor 1997-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

Sponsor landscape (corticosteroid class)

  1. Kala Pharmaceuticals, Inc. · 2 drugs in this class
  2. Balmoral Medical company · 1 drug in this class
  3. Bausch & Lomb Incorporated · 1 drug in this class
  4. Cerium Pharmaceuticals, Inc. · 1 drug in this class
  5. Dr. Reddys Laboratories, SA · 1 drug in this class
  6. Edesa Biotech Inc. · 1 drug in this class
  7. Evon Medics LLC · 1 drug in this class
  8. Federal University of São Paulo · 1 drug in this class
  9. Khon Kaen University · 1 drug in this class
  10. LEO Pharma · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). SNP-ACTH (1-39) Gel — Competitive Intelligence Brief. https://druglandscape.com/ci/snp-acth-1-39-gel. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: